Northbrook, IL (PRWEB) March 23, 2013 -- Pharma Start, LLC, a new functional outsourcing firm focused on the pharmaceutical, biopharmaceutical and device industries, opened its doors in March 2013. Specializing in the strategy and delivery of early phase development and medical writing, Pharma Start combines a functional outsourcing delivery model with scientific and medical research expertise to offer a single, reliable bridge into the drug development realm. Pharma Start service offerings range from first-in-human studies to regulatory approval and beyond.
Company Principal and President, Dr. Christina Fleming, is a highly respected leader in the pharmaceutical industry. Over the past 20+ years, Dr. Fleming and the Pharma Start Leadership Team have built, led, and managed clinical and medical teams in both industry sponsor and vendor environments. “Pharma Start is excited about the opportunity to collaborate with clients to develop optimal research strategies and to contribute to clinical trial research innovation and development,” Dr. Fleming said. “We look forward to partnering with our clients to enhance the bridge between science and medicine”.
About Pharma Start: Pharma Start is a functional outsourcing firm focused on the pharmaceutical, biotechnology, and devices industries. Pharma Start services include preclinical assessment (translational modeling), early phase clinical development, and regulatory submission/approval and life cycle management. http://www.pharma-start.com.
Dr. Christina Fleming
President and Chief Scientific Officer
Pharma Start, LLC
Toll Free: (888) 330-1726